Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Wet Age-related Macular Degeneration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03278262
What this trial is testing

The Impact of Baseline Visual Acuity on the Treatment Outcomes in Patients Treated With AflIbercept in Real-life Clinical Setting

Who this might be right for
Wet Macular Degeneration
Bayer 2,312
Testing effectiveness (Phase 2)Study completedNCT04486963
What this trial is testing

A Phase Ⅱ Clinical Study of Sanhuangjingshimingwan in Wet( Neovascular)Age-related Macular Degeneration(wAMD) Subjects

Who this might be right for
Age-related Macular Degeneration
Tasly Pharmaceutical Group Co., Ltd 78
Not applicableActive Not RecruitingNCT06518512
What this trial is testing

Automated Vision Assessment and Impairment Detection Through Gaze Analysis in Wet AMD Patients

Who this might be right for
Age-Related Macular DegenerationWet Age-related Macular Degeneration
Tan Tock Seng Hospital 128
Large-scale testing (Phase 3)UnknownNCT01255774
What this trial is testing

Serial Retinal Thickness Changes And Scotoma Size Measured With Lucentis Therapy

Who this might be right for
Age Related Macular Degeneration
The New York Eye & Ear Infirmary 20
Large-scale testing (Phase 3)Looking for participantsNCT04663750
What this trial is testing

Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER).

Who this might be right for
Eye DiseasesMacular Degeneration, WetSub-Macular Hemorrhage
King's College Hospital NHS Trust 210
Testing effectiveness (Phase 2)Looking for participantsNCT07811726
What this trial is testing

NT-101 Topical in Patients With Wet AMD

Who this might be right for
Wet Age Related Macular Degeneration
NexThera Co., Ltd. 66
Not applicableUnknownNCT04640649
What this trial is testing

Prediction of Progression of Age-Related Macular Degeneration

Who this might be right for
Macular DegenerationMacular Degeneration, WetMacular Degeneration, Dry
University of Illinois at Chicago 278
Not applicableActive Not RecruitingNCT01115387
What this trial is testing

GARM II: A Study on the Genetics of Age-related Maculopathy

Who this might be right for
Age-related Macular DegenerationAge-related Maculopathy
University of California, Los Angeles 603
Testing effectiveness (Phase 2)Study completedNCT04993352
What this trial is testing

Evaluate the Safety and Efficacy of HLX04-O in Subjects With wAMD

Who this might be right for
Age Related Macular Degeneration
Shanghai Henlius Biotech 20
Large-scale testing (Phase 3)Active Not RecruitingNCT04704921
What this trial is testing

Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD

Who this might be right for
AMDnAMDWet Age-related Macular Degeneration+6 more
AbbVie 671
Not applicableStudy completedNCT01448538
What this trial is testing

Non-Persistence/Non-Adherence (NP/NA) in Wet Age-related Macular Degeneration (wAMD) Patients in Germany

Who this might be right for
Wet Macular Degeneration
Bayer 480
Not applicableNot Yet RecruitingNCT07338513
What this trial is testing

User-centric Study of Patients' Receptiveness Towards the Web-based Automated Vision Impairment Gaze-tracking Analysis Systems

Who this might be right for
Age-Related Macular DegenerationWet Age-related Macular Degeneration
Tan Tock Seng Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT06492863
What this trial is testing

Gene Therapy(FT-003) for Wet AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Frontera Therapeutics 78
Not applicableStudy completedNCT05131646
What this trial is testing

Extension Study to Evaluate the Long-term Outcomes of Subjects in the CLS-AX CLS1002-101 Study

Who this might be right for
Neovascular Age-related Macular Degeneration
Clearside Biomedical, Inc. 15
Not applicableStudy completedNCT02541084
What this trial is testing

Caregiver Burden of Wet Age-related Macular Degeneration (wAMD) in Japan

Who this might be right for
Wet Macular Degeneration
Bayer 72
Testing effectiveness (Phase 2)Study completedNCT01674569
What this trial is testing

Pilot Study of X-82 in Patients With Wet AMD

Who this might be right for
Exudative Macular Degeneration
Tyrogenex 35
Large-scale testing (Phase 3)Ended earlyNCT00139282
What this trial is testing

A Safety and Efficacy Study of Squalamine Lactate for Injection (MSI-1256F) for "Wet" Age-Related Macular Degeneration

Who this might be right for
"Wet" Age-Related Macular Degeneration
Genaera Corporation
Not applicableStudy completedNCT02173496
What this trial is testing

Colour Contrast Sensitivity for the Early Detection of Wet Age-related Macular Degereration (CEDAR)

Who this might be right for
Age Related Macular Degeneration
Aston University 233
Testing effectiveness (Phase 2)Study completedNCT01243086
What this trial is testing

OZURDEX in Age Related Macular Degeneration as Adjunct to Ranibizumab

Who this might be right for
Wet Macular Degeneration
McMaster University 10
Not applicableStudy completedNCT01773954
What this trial is testing

Repeated Eye Injections of Aflibercept for Treatment of Wet Age Related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationMacular Degeneration
MidAtlantic Retina 40
Next Page